Study on Urinary Caffeine and Caffeine Metabolite Levels in American Adults with Coronary Heart Disease: A Cross-Sectional NHANES Study (2009-2014)
Arquivos Brasileiros de Cardiologia · 2025 · 122 (9)
DOI: 10.36660/abc.20240425i ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Arquivos Brasileiros de Cardiologia, 2025. Verfasst von Qianqian Li und 5 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Shenzhen Science and Technology Innovation Foundation, Guangdong-Shenzhen Joint Fund Youth.
Abstract (Originalsprache)
Background
In recent years, the impact of diet and lifestyle on coronary heart disease (CHD) has garnered significant attention. Caffeine, a common dietary component, and its metabolites may influence cardiovascular health.
Objective
This study aimed to investigate the association between urinary levels of caffeine and its metabolites and the incidence of CHD as well as to assess how these associations vary across different population groups.
Methods
Data from the NHANES database (2009-2014) were analyzed using multivariable logistic regression models and smooth curve fitting techniques. Participants were categorized into a control group (n = 5,005) and a CHD group (n = 222) based on CHD status. Urinary levels of caffeine and its metabolites were measured and recorded. Multivariable logistic regression was used to evaluate the association between urinary caffeine/metabolite levels and CHD incidence, while smooth curve fitting was employed to explore potential nonlinear relationships. A significance level of 5% was used to determine statistical significance.
Results
Higher urinary paraxanthine levels were associated with a lower risk of CHD. In contrast, elevated urinary caffeine levels were positively associated with CHD incidence among Mexican Americans, an association not observed in other racial/ethnic groups.
Conclusion
Lower urinary paraxanthine levels may reflect a reduced risk of CHD, while higher urinary caffeine levels could indicate an increased CHD risk in specific populations.
Förderung
- The Shenzhen Science and Technology Innovation Foundation
- Guangdong-Shenzhen Joint Fund Youth
Zitieren
APA
Li, Q., Ke, G., Liu, M., Chen, Y., Luo, Y., & Qiu, L. (2025). Study on Urinary Caffeine and Caffeine Metabolite Levels in American Adults with Coronary Heart Disease: A Cross-Sectional NHANES Study (2009-2014). Arquivos Brasileiros de Cardiologia, 122(9). https://doi.org/10.36660/abc.20240425i
Vancouver
Li Q, Ke G, Liu M, Chen Y, Luo Y, Qiu L. Study on Urinary Caffeine and Caffeine Metabolite Levels in American Adults with Coronary Heart Disease: A Cross-Sectional NHANES Study (2009-2014). Arquivos Brasileiros de Cardiologia. 2025;122(9). doi:10.36660/abc.20240425i
BibTeX
@article{Li2025,
author = {Li, Qianqian and Ke, Gan and Liu, Mengdie and Chen, Yanjun and Luo, Ye and Qiu, Liangxian},
title = {Study on Urinary Caffeine and Caffeine Metabolite Levels in American Adults with Coronary Heart Disease: A Cross-Sectional NHANES Study (2009-2014)},
journal = {Arquivos Brasileiros de Cardiologia},
year = {2025},
volume = {122},
number = {9},
doi = {10.36660/abc.20240425i}
}
EUVIMED